ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

ThromboGenics NV 

Gaston Geenslaan 1

Heverlee    B-3001  Belgium
Phone: 32-0-16-751310 Fax: 32-0-16-751311


SEARCH JOBS








 Company News
ThromboGenics NV (TBGNF) Appoints Dr. Joseph Markoff As Scientific Advisor 3/5/2015 9:39:29 AM
ThromboGenics NV (TBGNF) Receives Positive CHMP Opinion For Ready Diluted Formulation Of JETREA 3/3/2015 7:24:06 AM
ThromboGenics NV (TBGNF) Awarded EU1.1 Million IWT Research Grant 2/5/2015 8:05:36 AM
ThromboGenics NV (TBGNF) Appoints Emmanuele Attout As Independent Non-Executive Director 1/22/2015 8:21:48 AM
ThromboGenics NV (TBGNF) Appoints Dominique Vanfleteren As New Chief Financial Officer 1/7/2015 7:58:39 AM
ThromboGenics NV (TBGNF)'s' Commitment To The U.S. Retina Community Highlighted At American Association Of Ophthalmology 2014 Meeting 10/15/2014 7:32:37 AM
ThromboGenics NV (TBGNF)' JETREA® Gains Approval In South Korea 9/8/2014 7:44:45 AM
Belgium Biotech ThromboGenics NV (TBGNF) Cuts Around A Fifth Of Employees 9/2/2014 6:40:01 AM
ThromboGenics NV (TBGNF) Business Update H1 2014 8/27/2014 11:19:10 AM
ThromboGenics NV (TBGNF)' JETREA Receives Positive Recommendation From Scottish Medicines Consortium (SMC) 8/11/2014 10:53:02 AM
1234567